Literature DB >> 23274998

Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011.

Sehee Park1, Jin Il Kim, Ilseob Lee, Sangmoo Lee, Min-Woong Hwang, Joon-Yong Bae, Jun Heo, Eun-Joo Lim, Won-Seok Seok, Hee Jin Cheong, Joon Young Song, Woo Joo Kim, Man-Seong Park.   

Abstract

During the 2009-2011 influenza seasons, 10.26% of the specimens isolated from patients in South Korea were subtyped as H3N2 viruses. Some oseltamivir-sensitive H3N2 samples exhibited different plaque morphologies, and were found to have novel mutations in the neuraminidase gene. In a subsequent analysis using NA mutant viruses, viral compensation against oseltamivir treatment was observed only in the N2 mutant virus. All things considered, these novel mutations may account for the exclusive characteristics of selected H3N2 viruses observed in plaque reduction assays.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23274998     DOI： 10.1007/s12275-012-2541-3

Source DB:  PubMed          Journal:  J Microbiol        ISSN： 1225-8873            Impact factor:   3.422


  18 in total

Review 1.  Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors.

Authors:  M Tisdale
Journal:  Rev Med Virol       Date:  2000 Jan-Feb       Impact factor: 6.989

2.  GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents.

Authors:  Jin Il Kim; Sehee Park; Ilseob Lee; Sangmoo Lee; Saem Shin; Yongkwan Won; Min-Woong Hwang; Joon-Yong Bae; Jun Heo; Hye-Eun Hyun; Hyejin Jun; Soon Sung Lim; Man-Seong Park
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

3.  Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models.

Authors:  Donghyok Kwon; Kyeongcheol Shin; Seungtae Kim; Yooncheol Ha; Jang-Hoon Choi; Jeong Seon Yang; Joo-Yeon Lee; Chanhee Chae; Hee-Bok Oh; Chun Kang
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

4.  Influenza activity--United States and worldwide, 2007-08 season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-06-27       Impact factor: 17.586

5.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

Review 6.  Influenza virus susceptibility and resistance to oseltamivir.

Authors:  Fred Y Aoki; Guy Boivin; Noel Roberts
Journal:  Antivir Ther       Date:  2007

7.  Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

Authors:  J McKimm-Breschkin; T Trivedi; A Hampson; A Hay; A Klimov; M Tashiro; F Hayden; M Zambon
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.

Authors:  Larisa V Gubareva
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

9.  Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.

Authors:  Margaret Okomo-Adhiambo; Katrina Sleeman; Kristina Ballenger; Ha T Nguyen; Vasiliy P Mishin; Tiffany G Sheu; James Smagala; Yan Li; Alexander I Klimov; Larisa V Gubareva
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

10.  Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Authors:  Siri H Hauge; Susanne Dudman; Katrine Borgen; Angie Lackenby; Olav Hungnes
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883
View more
  3 in total

1.  The anti-influenza virus effect of Phellinus igniarius extract.

Authors:  Sangmoo Lee; Jin Il Kim; Jun Heo; Ilseob Lee; Sehee Park; Min-Woong Hwang; Joon-Yong Bae; Mee Sook Park; Hyoung Jin Park; Man-Seong Park
Journal:  J Microbiol       Date:  2013-10-31       Impact factor: 3.422

2.  Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Authors:  Dimitris Petridis; Paul Zarogoulidis; Anastasios Kallianos; Ioannis Kioumis; Georgia Trakada; Dionysios Spyratos; Antonis Papaiwannou; Konstantinos Porpodis; Haidong Huang; Aggeliki Rapti; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Ther Clin Risk Manag       Date:  2014-02-07       Impact factor: 2.423

3.  Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Sangmoo Lee; Min-Woong Hwang; Joon-Yong Bae; Jun Heo; Donghwan Kim; Seok-Il Jang; Hyejin Kim; Hee Jin Cheong; Jin-Won Song; Ki-Joon Song; Luck Ju Baek; Man-Seong Park
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.